Neoplasms Metastasis Terminated Phase 3 Trials for Zoledronic acid (DB00399)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00130494Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone LesionsTreatment
NCT00099203A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTreatment
NCT00099177A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainTreatment